Edap Tms (NASDAQ:EDAP)‘s stock had its “buy” rating reiterated by HC Wainwright in a note issued to investors on Wednesday, November 22nd. They currently have a $6.50 price objective on the medical equipment provider’s stock. HC Wainwright’s price target would indicate a potential upside of 127.27% from the company’s current price.
A number of other equities analysts have also commented on the stock. Zacks Investment Research lowered shares of Edap Tms from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 29th. ValuEngine raised shares of Edap Tms from a “sell” rating to a “hold” rating in a research report on Friday, October 6th.
Edap Tms (EDAP) opened at $2.86 on Wednesday. The firm has a market cap of $84.67, a PE ratio of 97.33 and a beta of 1.00. Edap Tms has a 1 year low of $2.25 and a 1 year high of $3.85. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.96 and a quick ratio of 2.35.
Edap Tms (NASDAQ:EDAP) last released its quarterly earnings results on Wednesday, November 15th. The medical equipment provider reported ($0.02) EPS for the quarter, hitting analysts’ consensus estimates of ($0.02). Edap Tms had a negative net margin of 5.36% and a positive return on equity of 5.89%. The business had revenue of $8.44 million for the quarter, compared to analyst estimates of $11.05 million. Edap Tms’s quarterly revenue was down 5.6% on a year-over-year basis. sell-side analysts predict that Edap Tms will post -0.01 EPS for the current fiscal year.
A number of institutional investors have recently made changes to their positions in EDAP. Essex Investment Management Co. LLC acquired a new stake in Edap Tms during the second quarter worth about $172,000. Hilton Capital Management LLC boosted its stake in shares of Edap Tms by 43.1% in the 2nd quarter. Hilton Capital Management LLC now owns 83,000 shares of the medical equipment provider’s stock valued at $274,000 after purchasing an additional 25,000 shares in the last quarter. Virtu KCG Holdings LLC acquired a new stake in shares of Edap Tms in the 2nd quarter valued at approximately $117,000. Finally, Archon Capital Management LLC acquired a new stake in shares of Edap Tms in the 2nd quarter valued at approximately $2,474,000. Hedge funds and other institutional investors own 10.47% of the company’s stock.
WARNING: This piece of content was originally published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international copyright laws. The original version of this piece of content can be read at https://www.thelincolnianonline.com/2017/12/08/edap-tms-edap-buy-rating-reaffirmed-at-hc-wainwright-updated-updated.html.
About Edap Tms
EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.
Receive News & Ratings for Edap Tms S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms S.A. and related companies with MarketBeat.com's FREE daily email newsletter.